68th Day Of Lockdown

Maharashtra65168280812197 Tamil Nadu2024611313157 Delhi173877846398 Gujarat1635692321007 Rajasthan83654855184 Madhya Pradesh78914444343 Uttar Pradesh77014651213 West Bengal48131775302 Andhra Pradesh3461228960 Bihar3359120915 Karnataka292299749 Telangana2499141277 Jammu and Kashmir234190828 Punjab2197194942 Odisha17239779 Haryana172194019 Kerala120957510 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chhatisgarh4471021 Chandigarh2891994 Tripura2711720 Himachal Pradesh223634 Goa70420 Manipur6060 Puducherry57230 Nagaland3600 Meghalaya27121 Arunachal Pradesh310 Mizoram110 Sikkim100
Business Other News 27 Oct 2018 Dr Reddy’s pos ...

Dr Reddy’s posts 77 per cent rise in PAT

DECCAN CHRONICLE.
Published Oct 27, 2018, 1:02 am IST
Updated Oct 27, 2018, 1:02 am IST
Speaking to the media Dr Reddy’s chief financial officer Saumen Chakraborty said, “There are multiple reasons for the growth in the profit.
Saumen Chakraborty
 Saumen Chakraborty

Hyderabad: Pharmaceutical major Dr Reddy’s on Friday said its profit after tax (PAT) for the July-September quarter was up by 77 per cent to Rs 504 crore against Rs 387.6 crore in the second quarter of FY18. 

Speaking to the media, Dr Reddy’s chief financial officer Saumen Chakraborty said, “There are multiple reasons for the growth in the profit. One is better business mix. And then product mix has also played a big role. Year-on-year improvement (of gross margins) primarily aided by contribution from new launches, improved leverage, better product mix coupled with favorable foreign exchange. This was partially offset by higher price erosions due to increased competitive intensity in some of our key molecules in the US.” 

 

Mr Chakraborty added, there was a gain of Rs 46.4 crore on account of sale of rights relating to Cloderm brand (including its authorized generic) and profit on sale of antibiotic manufacturing facility in Bristol, USA.

The company also its revenues from the global generics segment in the second quarter rise 7 per cent year on year to Rs 3,050 crore over the same quarter last year, primarily driven by contributions from emerging markets, India and favorable forex.

In a statement, CEO G.V. Prasad said that the continuous focus on execution, operational efficiency and cost optimisation are showing results. 

...
Location: India, Telangana, Hyderabad




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT